In Vivo CAR-T and the Future of Cell Therapy: Inside the $2.1B AbbVie Buyout of Capstan Therapeutics

In this episode of the BCI Podcast, Dr. Manish Kumar sits down with Dr. Christian Homsy, founder & CEO of Capstan Therapeutics, to explore his inspiring journey from a curious child in Lebanon to a pioneering leader in biotechnology and cell therapy.

Dr. Homsy shares how he transitioned from medicine to entrepreneurship, the lessons he learned founding Celiad, and how those experiences shaped the creation of Capstan Therapeutics—a company at the forefront of in vivo precision engineering using lipid nanoparticles.

💡 Topics include:

• The challenges and rewards of moving from medicine to biotech entrepreneurship

• Lessons from Celiad and their impact on Capstan’s foundation

• The game-changing role of lipid nanoparticles in drug delivery

• Navigating fundraising across Europe vs. the US

• The importance of resilience, patience, and building strong teams

• Leaving a legacy and shaping the future of medicine

🎙️ Whether you’re an aspiring entrepreneur, biotech enthusiast, or simply curious about the future of medicine, this episode is packed with insights on innovation, resilience, and impact.

🔑 Key Takeaways:

• Curiosity and passion drive innovation

• Resilience is essential in leadership and entrepreneurship

• In vivo therapies could revolutionize treatment approaches

• Strong teams and patience are key to long-term success

✨ Don’t forget to like, comment, and subscribe for more conversations with leaders shaping the future of biotechnology and innovation.